methoxyhydroxyphenylglycol has been researched along with Genetic Predisposition in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (85.71) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agartz, I; Andreou, D; Bjerkenstedt, L; Comasco, E; Flyckt, L; Johansson, J; Jönsson, EG; Lewander, T; Oreland, L; Söderman, E; Terenius, L; Toffoletto, S; Venizelos, N; Vumma, R | 1 |
Agartz, I; Andreou, D; Edman-Ahlbom, B; Gunnar, A; Hall, H; Jönsson, EG; Saetre, P; Sedvall, G; Sillén, A; Terenius, L | 1 |
Currier, D; Galfalvy, H; Huang, YY; Mann, JJ; Oquendo, MA | 1 |
Agren, H; Aklillu, E; Karlsson, S; Ozdemir, V; Zachrisson, OO | 1 |
Aklillu, E; Bertilsson, L; Heikkinen, T; Hilli, J; Kishida, I; Laine, K; Lehtimäki, T; Rontu, R; Vahlberg, T | 1 |
Anguiano, JB; Arrúe, A; Basterreche, N; Dávila, R; Zamalloa, MI; Zumárraga, M | 1 |
Agren, H; Aklillu, E; Bertilsson, L; Kawanishi, C; Kishida, I | 1 |
7 other study(ies) available for methoxyhydroxyphenylglycol and Genetic Predisposition
Article | Year |
---|---|
Genetic and Functional Study of L-Type Amino Acid Transporter 1 in Schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cells, Cultured; Female; Fibroblasts; Genetic Predisposition to Disease; Homovanillic Acid; Humans; Large Neutral Amino Acid-Transporter 1; Male; Methoxyhydroxyphenylglycol; Middle Aged; Polymorphism, Single Nucleotide; Protein Isoforms; Schizophrenia; Tyrosine; Young Adult | 2016 |
Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.
Topics: Adult; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurocognitive Disorders; Norepinephrine; Polymorphism, Genetic; Predictive Value of Tests; Serotonin; Young Adult | 2008 |
Increased risk of suicide attempt in mood disorders and TPH1 genotype.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Black or African American; Depressive Disorder, Major; Female; Genetic Predisposition to Disease; Haplotypes; Hispanic or Latino; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Mood Disorders; New York; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Sex Factors; Suicide, Attempted; Tryptophan Hydroxylase; White People; Young Adult | 2009 |
Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression.
Topics: Case-Control Studies; Depression; Dopamine; Female; Genetic Predisposition to Disease; Genetic Variation; Humans; Hydroxyindoleacetic Acid; Logistic Models; Male; Methoxyhydroxyphenylglycol; Models, Biological; Monoamine Oxidase; Polymorphism, Genetic; Promoter Regions, Genetic; Scandinavian and Nordic Countries; Sex Factors; White People | 2009 |
MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.
Topics: Catechol O-Methyltransferase; Child; Child, Preschool; Cytochrome P-450 Enzyme System; Depression; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Polymorphism, Genetic; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prolactin; Prospective Studies; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Syndrome; Statistics, Nonparametric | 2009 |
Influence of the catechol-O-methyltransferase Val108/158Met polymorphism on the plasma concentration of catecholamine metabolites and on clinical features in type I bipolar disorder--a preliminary report.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biogenic Monoamines; Bipolar Disorder; Catechol O-Methyltransferase; Drug Therapy, Combination; Female; Gene Expression; Genetic Predisposition to Disease; Genotype; Homovanillic Acid; Humans; Lithium Carbonate; Male; Methoxyhydroxyphenylglycol; Middle Aged; Olanzapine; Polymorphism, Genetic; Prevalence; Psychotic Disorders; Severity of Illness Index; Treatment Outcome | 2006 |
Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.
Topics: Adult; Aged; Biogenic Monoamines; Brain Chemistry; Depressive Disorder; DNA Mutational Analysis; Drug Resistance; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Mutation; Polymorphism, Genetic; Serotonin Plasma Membrane Transport Proteins; Tandem Repeat Sequences; Up-Regulation | 2007 |